These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1821979)

  • 1. [Effect of thymoleptics on hemodynamic indicators and prediction of the effectiveness of the treatment of endogenous depression].
    Jakitowicz J; Magiera P; Smoczyński S
    Psychiatr Pol; 1991; 25(3-4):55-61. PubMed ID: 1821979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in hemodynamic indicators during doxepin therapy as a prognostic factor in the treatment of endogenous depression].
    Magiera P; Smoczyński S; Jakitowicz J
    Psychiatr Pol; 1991; 25(3-4):44-50. PubMed ID: 1821977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the effect of mianserin om hemodynamic indicators in patients with endogenous depression].
    Jakitowicz J; Magiera P; Smoczyński S
    Psychiatr Pol; 1991; 25(3-4):51-4. PubMed ID: 1821978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Various hemodynamic indicators in patients with endogenous depression before and during amitriptyline treatment].
    Magiera P; Smoczyński S
    Psychiatr Pol; 1989; 23(1):18-23. PubMed ID: 2813618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amitriptyline-perphenazine and doxepin in depressed outpatients: a controlled double-blind study.
    Rickels K; Csanalosi I; Werblowsky J; Weise CC; Weinstock R; Brown AS; Winokur A; Von Poelnitz M
    J Clin Psychiatry; 1982 Oct; 43(10):419-22. PubMed ID: 6749826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Monitoring of the treatment of endogenous depression with imipramine and amitriptyline (preliminary report)].
    Rybakowski J; Matkowski K; Linka M; Kasprowicz-Dabrowiecka A; Kanarkowski R; Lehmann W; Krzyzanowski M
    Psychiatr Pol; 1991; 25(3-4):111-8. PubMed ID: 1821970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double blind comparative study of mianserin and a fixed combination of amitriptyline plus chlordiazepoxide.
    Dimitriou EC; Logothetis JA; Paschalidou M
    Adv Biochem Psychopharmacol; 1982; 32():213-22. PubMed ID: 7046365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early results of the treatment of endogenous depression with tricyclic antidepressive drugs and prognosis of their effectiveness].
    Beresewicz M; Bidzińska E; Koszewska I; Puzyński S
    Psychiatr Pol; 1991; 25(3-4):25-31. PubMed ID: 1821973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of severe depressive illness: a double-blind comparison of mianserin and long-acting amitriptyline.
    Khan MC; Ancill RJ; Davey A
    Br J Clin Pract; 1982 Jun; 36(6):240-2. PubMed ID: 6756455
    [No Abstract]   [Full Text] [Related]  

  • 10. Treating the depressed elderly patient: the comparative behavioral pharmacology of mianserin and amitriptyline.
    Branconnier RJ; Cole JO; Ghazvinian S; Rosenthal S
    Adv Biochem Psychopharmacol; 1982; 32():195-212. PubMed ID: 7046364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J; Barkin RL
    J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind study.
    Altintoprak AE; Zorlu N; Coskunol H; Akdeniz F; Kitapcioglu G
    Hum Psychopharmacol; 2008 Jun; 23(4):313-9. PubMed ID: 18327889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary MHPG is not a good predictor of antidepressive drug response.
    Puzyński S; Rode A; Bidziński A; Mrozek S; Załuska M
    Pol J Pharmacol Pharm; 1984; 36(4):329-35. PubMed ID: 6527968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of amitriptyline, doxepin, fluvoxamine, and paroxetine treatment on heart rate variability.
    Rechlin T
    J Clin Psychopharmacol; 1994 Dec; 14(6):392-5. PubMed ID: 7884019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The comparative studies of therapeutic results in patients with psychotic refractory depression treated with selected antidepressants and unilateral ECT].
    Hese RT; Gruszczyński W; Szwed A; Kielc M; Zalitacz M
    Psychiatr Pol; 2002; 36(6 Suppl):81-4. PubMed ID: 12647425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled study of mianserin in moderately to severely depressed outpatients.
    Carman JS; Ahdieh H; Wyatt-Knowles E; Warga E; Panagides J
    Psychopharmacol Bull; 1991; 27(2):135-9. PubMed ID: 1924659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
    Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S
    Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Salivation test in patients with affective disorders treated with amitriptyline, mianserin and electroconvulsive therapy].
    Hese RT
    Psychiatr Pol; 1992; 26(1-2):29-36. PubMed ID: 1298001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.
    Bremner JD
    J Clin Psychiatry; 1995 Nov; 56(11):519-25. PubMed ID: 7592505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic drug monitoring of tricyclic antidepressants: how does it work under clinical conditions?
    Müller MJ; Dragicevic A; Fric M; Gaertner I; Grasmäder K; Härtter S; Hermann E; Kuss HJ; Laux G; Oehl W; Rao ML; Rollmann N; Weigmann H; Weber-Labonte M; Hiemke C
    Pharmacopsychiatry; 2003 May; 36(3):98-104. PubMed ID: 12806567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.